Compare Stocks

→ Move Your Money Before May 1 (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DFFN Diffusion Pharmaceuticals		$4.64	$2.76 ▼ $7.40	$8.98M	1.78	10,937 shs	351,000 shs
EYEG AB Corporate Bond ETF	$34.74 +0.3%	$1.90	$1.44 ▼ $8.18	$24.31M	0.13	935,975 shs	300 shs
PHIO Phio Pharmaceuticals	$0.68 -2.8%	$0.80	$0.50 ▼ $6.85	$3.13M	1.44	366,014 shs	106,030 shs
SUWN Sunwin Stevia International	$0.00	$0.00	$0.00 ▼ $0.03	$60K	-0.53	1,050 shs	N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DFFN Diffusion Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-22.60%
EYEG AB Corporate Bond ETF	-0.28%	-0.09%	-2.67%	-2.73%	+1,675.58%
PHIO Phio Pharmaceuticals	+5.22%	+11.18%	-3.29%	+28.34%	-78.67%
SUWN Sunwin Stevia International	0.00%	0.00%	0.00%	0.00%	-96.39%

Move Your Money Before May 1 (Ad)

Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?

Click here to get the full story before May 1.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHIO Phio Pharmaceuticals	2.1414 of 5 stars	3.5	3.0	0.0	0.0	0.8	2.5	0.6
SUWN Sunwin Stevia International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	N/A	N/A	N/A	N/A
PHIO Phio Pharmaceuticals	3.00	Buy	$4.00	486.51% Upside
SUWN Sunwin Stevia International	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest EYEG, DFFN, PHIO, and SUWN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
2/6/2024	PHIO Phio Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$6.00 ➝ $4.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	$6.97 per share	N/A
EYEG AB Corporate Bond ETF	$10K	2,431.45	N/A	N/A	$1.26 per share	27.57
PHIO Phio Pharmaceuticals	N/A	N/A	N/A	N/A	$2.06 per share	N/A
SUWN Sunwin Stevia International	$35.26M	0.00	N/A	N/A	$0.02 per share	0.02

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DFFN Diffusion Pharmaceuticals	-$15.59M	N/A	0.00	N/A	N/A	N/A	-69.96%	-62.98%	N/A
EYEG AB Corporate Bond ETF	-$8.09M	-$1.68	N/A	N/A	N/A	N/A	-104.96%	-60.03%	N/A
PHIO Phio Pharmaceuticals	-$10.83M	-$5.93	N/A	∞	N/A	N/A	-134.66%	-105.86%	5/9/2024 (Estimated)
SUWN Sunwin Stevia International	-$2.91M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest EYEG, DFFN, PHIO, and SUWN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/1/2024	Q4 2023	PHIO Phio Pharmaceuticals	N/A	-$0.17	-$0.17	-$0.17	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DFFN Diffusion Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
EYEG AB Corporate Bond ETF	N/A	N/A	N/A	N/A	N/A
PHIO Phio Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
SUWN Sunwin Stevia International	N/A	N/A	N/A	N/A	N/A

Latest EYEG, DFFN, PHIO, and SUWN Dividends

Announcement	Company	Period	Amount	Ex-Dividend Date	Record Date	Payable Date
3/28/2024	EYEG AB Corporate Bond ETF	Monthly	$0.1572	4/1/2024	4/2/2024	4/5/2024
2/29/2024	EYEG AB Corporate Bond ETF	Monthly	$0.1486	3/1/2024	3/4/2024	3/7/2024
1/31/2024	EYEG AB Corporate Bond ETF	Monthly	$0.1476	2/1/2024	2/2/2024	2/7/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DFFN Diffusion Pharmaceuticals	N/A	10.71	10.71
EYEG AB Corporate Bond ETF	0.01	3.07	3.07
PHIO Phio Pharmaceuticals	N/A	5.70	5.71
SUWN Sunwin Stevia International	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
DFFN Diffusion Pharmaceuticals	9.95%
EYEG AB Corporate Bond ETF	64.16%
PHIO Phio Pharmaceuticals	57.31%
SUWN Sunwin Stevia International	N/A

Insider Ownership

Company	Insider Ownership
DFFN Diffusion Pharmaceuticals	1.80%
EYEG AB Corporate Bond ETF	58.20%
PHIO Phio Pharmaceuticals	0.77%
SUWN Sunwin Stevia International	0.90%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
DFFN Diffusion Pharmaceuticals	13	2.04 million	2.00 million	Not Optionable
EYEG AB Corporate Bond ETF	14	700,000	5.28 million	Not Optionable
PHIO Phio Pharmaceuticals	9	4.59 million	4.56 million	Not Optionable
SUWN Sunwin Stevia International	242	199.63 million	197.84 million	Not Optionable

EYEG, DFFN, PHIO, and SUWN Headlines

Source	Headline
	10 Best Stevia Sweetners msn.com - July 18 at 3:05 PM
	Homeware department and cafe at Bradford's much-missed Sunwin House thetelegraphandargus.co.uk - May 8 at 8:19 AM
	Sunwin Stevia International Year to Date Total Returns (Daily) ycharts.com - December 17 at 11:05 PM
	Sunwin Stevia International Inc. barrons.com - August 12 at 10:28 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Diffusion Pharmaceuticals

NASDAQ:DFFN

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

AB Corporate Bond ETF

NASDAQ:EYEG

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Phio Pharmaceuticals

NASDAQ:PHIO

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. The company develops PH-762, INTASYL compound which reduces the expression of cell death Protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; PH-894 that silences the BRD4, a protein which controls gene expression in both T cells and tumor cells, effecting the immune system as well as the tumor; and PH-804 that targets the TIGIT, a protein which inhibits the activity of Natural Killer cells. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.

Sunwin Stevia International

OTCMKTS:SUWN

Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It offers Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trade companies. The company also produces and sells Metformin, a medication for the treatment of type 2 diabetes. Sunwin Stevia International, Inc. is based in Qufu, China.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial